Q96Q83 (ALKB3_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 100.
History...
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 EC=1.14.11.- Alternative name(s): Alkylated DNA repair protein alkB homolog 3 DEPC-1 Prostate cancer antigen 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 286 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Dioxygenase that repairs alkylated DNA containing 1-methyladenine (1meA) and 3-methylcytosine (3meC) by oxidative demethylation. Has a strong preference for single-stranded DNA. Able to process alkylated 3mC within double-stranded regions via its interaction with ASCC3, which promotes DNA unwinding to generate single-stranded substrate needed for ALKHB3. May also act on RNA. Requires molecular oxygen, alpha-ketoglutarate and iron. Ref.6 Ref.7 Ref.8 Ref.10 |
| Cofactor | Binds 1 Fe2+ ion per subunit. |
| Enzyme regulation | Activated by ascorbate. Ref.6 |
| Subunit structure | Interacts with the TRIP4 complex, notably composed of ASCC3. Ref.10 |
| Subcellular location | |
| Tissue specificity | Ubiquitous. Detected in heart, pancreas, skeletal muscle, thymus, testis, ovary, spleen, prostate, small intestine, peripheral blood leukocytes, urinary bladder and colon. Ref.6 Ref.8 Ref.9 |
| Sequence similarities | Belongs to the alkB family. Contains 1 Fe2OG dioxygenase domain. |
| Sequence caution | The sequence AAH15155.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
Alternative products
| This entry describes 2 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q96Q83-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q96Q83-2) The sequence of this isoform differs from the canonical sequence as follows: 73-74: DR → E 125-172: ITYQQPRLTA...NRIEENTGHT → SILQLTFKKS...ILTRTRLWAP 173-286: Missing. | ||||||
| Note: No experimental confirmation available. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 286 | 286 | Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3 | PRO_0000239278 | ||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 172 – 278 | 107 | Fe2OG dioxygenase | |||||||||||||||||||||||||||||||||||||||||||||
| Region | 141 – 143 | 3 | Substrate binding By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Region | 179 – 181 | 3 | Alpha-ketoglutarate binding | |||||||||||||||||||||||||||||||||||||||||||||
| Region | 269 – 275 | 7 | Alpha-ketoglutarate binding | |||||||||||||||||||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 191 | 1 | Iron; catalytic | |||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 193 | 1 | Iron; catalytic | |||||||||||||||||||||||||||||||||||||||||||||
| Metal binding | 257 | 1 | Iron; catalytic | |||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 115 | 1 | Substrate By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Binding site | 194 | 1 | Substrate By similarity | |||||||||||||||||||||||||||||||||||||||||||||
| Site | 177 | 1 | Susceptible to oxidation | |||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 73 – 74 | 2 | DR → E in isoform 2. | VSP_019125 | ||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 125 – 172 | 48 | ITYQQ…NTGHT → SILQLTFKKSAPVSGTATAP QSCWYERPSPPHIPGPAILT RTRLWAP in isoform 2. | VSP_019126 | ||||||||||||||||||||||||||||||||||||||||||||
| Alternative sequence | 173 – 286 | 114 | Missing in isoform 2. | VSP_019127 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 164 | 1 | R → C. Ref.2 Corresponds to variant rs2271815 [ dbSNP | Ensembl ]. | VAR_026632 | ||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 228 | 1 | D → E. Ref.2 Ref.5 Corresponds to variant rs2434470 [ dbSNP | Ensembl ]. | VAR_026631 | ||||||||||||||||||||||||||||||||||||||||||||
Experimental info | ||||||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 122 | 1 | R → A: Decreases activity towards ssDNA by 25%. Loss of activity towards dsDNA. | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 123 | 1 | E → A: Strongly increases activity towards dsDNA, possibly by facilitating access to the active site. | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 131 | 1 | R → A: Loss of activity. | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 177 | 1 | L → A or N: Loss of activity against 1-methyladenine. | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 177 | 1 | L → E or Q: Loss of activity. | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 177 | 1 | L → I: Decreases activity against 1-methyladenine. | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 177 | 1 | L → M: No effect. | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 179 | 1 | N → A: Decreases activity by about 60%. | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 181 | 1 | Y → A: Strong decrease of activity. | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 189 | 1 | D → A: Strongly increases activity towards dsDNA, possibly by facilitating access to the active site. | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 191 | 1 | H → A: Loss of activity. | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 193 | 1 | D → A: Loss of activity. Ref.8 | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 257 | 1 | H → A: Decreases activity by about 65%. Ref.8 Ref.10 | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 269 | 1 | R → A: Strong decrease of activity. | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 271 | 1 | N → A: No effect. | |||||||||||||||||||||||||||||||||||||||||||||
| Mutagenesis | 275 | 1 | R → A: Loss of activity. | |||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 74 – 81 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 84 – 86 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 88 – 93 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 99 – 112 | 14 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 119 – 124 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 126 – 128 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 130 – 137 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 145 – 148 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 151 – 153 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 156 – 169 | 14 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 175 – 181 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 188 – 191 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 196 – 198 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 204 – 211 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 213 – 219 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 234 – 239 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 244 – 249 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 251 – 254 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 255 – 259 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 269 – 275 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Homo sapiens mRNA expressed in prostate cancer and thymus." Tsujikawa K., Konishi N., Ono Y., Ichijou T., Sakamoto K., Yamamoto H. Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). Tissue: Fetal thymus and Prostatic carcinoma. |
| [2] | NIEHS SNPs program Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS CYS-164 AND GLU-228. |
| [3] | "Human chromosome 11 DNA sequence and analysis including novel gene identification." Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G. Sakaki Y.Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), VARIANT GLU-228. Tissue: Lung and PNS. |
| [6] | "Reversal of DNA alkylation damage by two human dioxygenases." Duncan T., Trewick S.C., Koivisto P., Bates P.A., Lindahl T., Sedgwick B. Proc. Natl. Acad. Sci. U.S.A. 99:16660-16665(2002) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, ENZYME REGULATION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [7] | "Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA." Aas P.A., Otterlei M., Falnes P.O., Vaagboe C.B., Skorpen F., Akbari M., Sundheim O., Bjoeraas M., Slupphaug G., Seeberg E., Krokan H.E. Nature 421:859-863(2003) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, SUBCELLULAR LOCATION. |
| [8] | "Repair of methylation damage in DNA and RNA by mammalian AlkB homologues." Lee D.-H., Jin S.-G., Cai S., Chen Y., Pfeifer G.P., O'Connor T.R. J. Biol. Chem. 280:39448-39459(2005) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, MUTAGENESIS OF ASP-193 AND HIS-257, TISSUE SPECIFICITY. |
| [9] | "Expression and sub-cellular localization of human ABH family molecules." Tsujikawa K., Koike K., Kitae K., Shinkawa A., Arima H., Suzuki T., Tsuchiya M., Makino Y., Furukawa T., Konishi N., Yamamoto H. J. Cell. Mol. Med. 11:1105-1116(2007) [PubMed] [Europe PMC] [Abstract] Cited for: SUBCELLULAR LOCATION, TISSUE SPECIFICITY. |
| [10] | "DNA unwinding by ASCC3 helicase is coupled to ALKBH3-dependent DNA alkylation repair and cancer cell proliferation." Dango S., Mosammaparast N., Sowa M.E., Xiong L.J., Wu F., Park K., Rubin M., Gygi S., Harper J.W., Shi Y. Mol. Cell 44:373-384(2011) [PubMed] [Europe PMC] [Abstract] Cited for: FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH ALKBH3, MUTAGENESIS OF HIS-257. |
| [11] | "Human ABH3 structure and key residues for oxidative demethylation to reverse DNA/RNA damage." Sundheim O., Vaagboe C.B., Bjoeraas M., Sousa M.M.L., Talstad V., Aas P.A., Drabloes F., Krokan H.E., Tainer J.A., Slupphaug G. EMBO J. 25:3389-3397(2006) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 70-286 IN COMPLEX WITH ALPHA-KETOGLUTARATE AND IRON, MASS SPECTROMETRY, OXIDATION AT LEU-177. |
| + | Additional computationally mapped references. |
Web resources
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | AB042029 mRNA. Translation: BAB70508.1. DQ196343 Genomic DNA. Translation: ABA27096.1. AC087521 Genomic DNA. No translation available. CH471064 Genomic DNA. Translation: EAW68078.1. BC015155 mRNA. Translation: AAH15155.1. Different initiation. BC103812 mRNA. Translation: AAI03813.1. BC103813 mRNA. Translation: AAI03814.1. BC103814 mRNA. Translation: AAI03815.1. BC067257 mRNA. Translation: AAH67257.1. | ||||||||||||
| IPI | IPI00076597. IPI00433171. | ||||||||||||
| RefSeq | NP_631917.1. NM_139178.3. | ||||||||||||
| UniGene | Hs.720708. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q96Q83. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| STRING | 9606.ENSP00000302232. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q96Q83. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 74752087. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q96Q83. | ||||||||||||
| PRIDE | Q96Q83. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000302708; ENSP00000302232; ENSG00000166199. ENST00000378840; ENSP00000368117; ENSG00000166199. ENST00000530803; ENSP00000436788; ENSG00000166199. | ||||||||||||
| GeneID | 221120. | ||||||||||||
| KEGG | hsa:221120. | ||||||||||||
| UCSC | uc001mxs.2. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 221120. | ||||||||||||
| GeneCards | GC11P043859. | ||||||||||||
| HGNC | HGNC:30141. ALKBH3. | ||||||||||||
| HPA | CAB005007. HPA009674. | ||||||||||||
| MIM | 610603. gene. | ||||||||||||
| neXtProt | NX_Q96Q83. | ||||||||||||
| PharmGKB | PA143485293. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG3145. | ||||||||||||
| HOGENOM | HOG000207105. | ||||||||||||
| HOVERGEN | HBG056732. | ||||||||||||
| InParanoid | Q96Q83. | ||||||||||||
| KO | K10860. | ||||||||||||
| OMA | DRGPRIN. | ||||||||||||
| OrthoDB | EOG41JZCZ. | ||||||||||||
| PhylomeDB | Q96Q83. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Reactome | REACT_216. DNA Repair. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q96Q83. | ||||||||||||
| Bgee | Q96Q83. | ||||||||||||
| CleanEx | HS_ALKBH3. | ||||||||||||
| Genevestigator | Q96Q83. | ||||||||||||
| GermOnline | ENSG00000166199. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR005123. Oxoglu/Fe-dep_dioxygenase. [Graphical view] | ||||||||||||
| Pfam | PF13532. 2OG-FeII_Oxy_2. 1 hit. [Graphical view] | ||||||||||||
| PROSITE | PS51471. FE2OG_OXY. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| DrugBank | DB00126. Vitamin C. | ||||||||||||
| EvolutionaryTrace | Q96Q83. | ||||||||||||
| GenomeRNAi | 221120. | ||||||||||||
| NextBio | 91204. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | ALKB3_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q96Q83 Secondary accession number(s): A6NDJ1 Q96BU8 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
